Literature DB >> 9577972

Quantitative analysis of the toxicity of human amniotic fluid to cultured rat spinal cord.

M J Drewek1, J P Bruner, W O Whetsell, N Tulipan.   

Abstract

It has been proposed that the myelodysplastic components of a myelomeningocele are secondarily damaged as the result of exposure to amniotic fluid, the so-called 'two-hit' hypothesis. The critical time at which this secondary insult might occur has not been clearly defined. The present study addresses this issue by quantitatively assessing the toxic effects of human amniotic fluid of various gestational ages upon organotypic cultures of rat spinal cord. Using an assay for lactate dehydrogenase efflux to evaluate toxicity in such spinal cord cultures, we found that the amniotic fluid became toxic at approximately 34 weeks' gestation. This toxic effect of amniotic fluid appears to emerge rather suddenly. Accordingly, it seems reasonable to suggest that prevention of exposure of vulnerable spinal cord tissue to this toxicity by surgical closure of a myelomeningocele defect prior to the emergence of toxicity in amniotic fluid may prevent injury to vulnerable myelodysplastic spinal cord tissue.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9577972     DOI: 10.1159/000121250

Source DB:  PubMed          Journal:  Pediatr Neurosurg        ISSN: 1016-2291            Impact factor:   1.162


  16 in total

1.  Assessment of neurosurgical outcome in children prenatally diagnosed with myelomeningocele and development of a protocol for fetal surgery to prevent hydrocephalus.

Authors:  Helder Zambelli; Edmur Carelli; Donizeti Honorato; Sérgio Marba; Giselle Coelho; Aline Carnevalle; Alexandre Iscaife; Elton da Silva; Ricardo Barini; Lourenço Sbragia
Journal:  Childs Nerv Syst       Date:  2007-01-17       Impact factor: 1.475

2.  The effect of prenatal treatment with steroids and preterm delivery in a model of myelomeningocele on the rabbit foetus.

Authors:  César G Fontecha; Jose L Peiró; Marius Aguirre; Francesc Soldado; Patricia Paz; Marc Oria; Núria Torán; Vicenç Martinez-Ibáñez
Journal:  Pediatr Surg Int       Date:  2007-05       Impact factor: 1.827

Review 3.  Fetal surgery for neural tube defects.

Authors:  Leslie N Sutton
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2007-08-22       Impact factor: 5.237

4.  Congenital myelomeningocele - do we have to change our management?

Authors:  Steffi Mayer; Margit Weisser; Holger Till; Gerd Gräfe; Christian Geyer
Journal:  Cerebrospinal Fluid Res       Date:  2010-10-14

5.  Expression of neuronal antigens and related ventral and dorsal proteins in the normal spinal cord and a surgically induced open neural tube defect of the spine in chick embryos: an immunohistochemical study.

Authors:  Do-Hun Lee; Ji Hoon Phi; You-Nam Chung; Yun-Jin Lee; Seung-Ki Kim; Byung-Kyu Cho; Dong Won Kim; Moon-Sik Park; Kyu-Chang Wang
Journal:  Childs Nerv Syst       Date:  2009-12-01       Impact factor: 1.475

6.  Fetal spina bifida in a mouse model: loss of neural function in utero.

Authors:  Dorothea Stiefel; Andrew J Copp; Martin Meuli
Journal:  J Neurosurg       Date:  2007-03       Impact factor: 5.115

7.  In spina bifida aperta, muscle ultrasound can quantify the "second hit of damage".

Authors:  R J Verbeek; J H van der Hoeven; N M Maurits; O F Brouwer; E W Hoving; D A Sival
Journal:  Childs Nerv Syst       Date:  2012-11-09       Impact factor: 1.475

8.  Fetal surgery for myelomeningocele.

Authors:  Leslie N Sutton; N Scott Adzick; Mark P Johnson
Journal:  Childs Nerv Syst       Date:  2003-07-15       Impact factor: 1.475

Review 9.  Spina bifida.

Authors:  Andrew J Copp; N Scott Adzick; Lyn S Chitty; Jack M Fletcher; Grayson N Holmbeck; Gary M Shaw
Journal:  Nat Rev Dis Primers       Date:  2015-04-30       Impact factor: 52.329

Review 10.  State of the art in translating experimental myelomeningocele research to the bedside.

Authors:  Lourenço Sbragia; Karina Miura da Costa; Antonio Landolffi Abdul Nour; Rodrigo Ruano; Marcelo Volpon Santos; Hélio Rubens Machado
Journal:  Childs Nerv Syst       Date:  2021-07-31       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.